TransCode Therapeutics Inc. Gains 55.58%
Wed, Sep 25, 2024 at 07:40 PM
TransCode Therapeutics Inc. (RNAZ:NASDAQ) rocketted at $0.65, a gain of 55.6%. On Wed, Sep 25, 2024, RNAZ:NASDAQ touched a New 2-Week High of $0.65. The stock appeared on our News Catalysts scanner on Tue, Sep 17, 2024 at 08:27 AM in the 'BIOTECH' category. From Wed, Sep 11, 2024, the stock recorded 60.00% Up Days and 54.55% Green Days
The stock spiked on Fri, May 10, 2024 at $2.01 with a volume of 13M+.
About TransCode Therapeutics Inc. (RNAZ:NASDAQ)
TransCode Therapeutics Inc is an RNA oncology company. It is created to defeat the cancer through the intelligent design and effective delivery of RNA therapeutics.
Top 10 Gainers:
- Tempo Automation Holdings Inc. (TMPO:NASDAQ), 84.62%
- Markforged Holding Corporation (MKFG:NYSE), 73.99%
- Vinco Ventures Inc. (BBIG:NASDAQ), 66.67%
- TransCode Therapeutics Inc. (RNAZ:NASDAQ), 55.58%
- Rezolve AI Limited (RZLV:NASDAQ), 52.85%
- Calithera Biosciences, Inc. (CALA:NASDAQ), 50%
- Alpha Technology Group Limited (ATGL:NASDAQ), 46.26%
- Eightco Holdings Inc Com (New) (OCTO:NASDAQ), 45.78%
- Motorsport Games Inc. (MSGM:NASDAQ), 38.74%
- Tenon Medical Inc. (TNON:NASDAQ), 34.08%